Sumitomo Pharma Co Ltd (STU:DPM)
€ 3.5 0.02 (0.57%) Market Cap: 1.41 Bil Enterprise Value: 3.06 Bil PE Ratio: 0 PB Ratio: 2.04 GF Score: 63/100

Q3 2024 Sumitomo Pharma Co Ltd Earnings Presentation Transcript

Jan 31, 2024 / NTS GMT
Release Date Price: €2.68 (-0.74%)
Koji Ishida
Sumitomo Pharma Co Ltd - VP, Head of Global Finance

Presentation
Jan 31, 2024 / NTS GMT

=====================
Corporate Participants
=====================
* Koji Ishida
Sumitomo Pharma Co Ltd - VP, Head of Global Finance
* Hiroshi Nomura
Sumitomo Pharma Co Ltd - Representative Director, President & CEO
* Toru Kimura
Sumitomo Pharma Co Ltd - Representative Director, Senior Managing Executive Officer
* Yoshiharu Ikeda
Sumitomo Pharma Co Ltd - Director, Managing Executive Officer

=====================
Conference Call Participants
=====================
* Seiji Wakao
JPMorgan Securities Japan Co., Ltd. - Analyst
* Hidemaru Yamaguchi
Citigroup Global Markets Japan Inc. - Analyst
* Shinichiro Muraoka
Morgan Stanley MUFG Securities Co., Ltd. - Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd. - Analyst
* Fumiyoshi Sakai
UBS Securities Japan Co., Ltd. - Analyst

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot